AIDS: Advanced HIV Infection – Symptoms, Complications & Management

Acquired Immunodeficiency Syndrome (AIDS) is the most advanced stage of HIV infection, defined by a CD4+ T-cell count <200 cells/μL or the presence of specific AIDS-defining illnesses. Without treatment, HIV typically progresses to AIDS over 8–10 years.

Pathophysiology

HIV targets CD4+ T-helper cells, progressively destroying cell-mediated immunity. This permits opportunistic pathogens and malignancies that a healthy immune system would control.

AIDS-Defining Conditions (CDC Category C)

Opportunistic Infections

  • Pneumocystis jirovecii pneumonia (PCP): Subacute dyspnea, dry fever, bilateral interstitial infiltrates.
  • Cryptococcal meningitis: Headache, fever, altered mental status; diagnosed by CSF cryptococcal antigen.
  • Cytomegalovirus (CMV) retinitis: Floaters, vision loss; "pizza pie" retinal hemorrhages.
  • Mycobacterium avium complex (MAC): Disseminated fever, weight loss, anemia; blood culture positive.
  • Toxoplasma gondii encephalitis: Ring-enhancing brain lesions; seizures, focal deficits.
  • Esophageal candidiasis: Odynophagia, retrosternal pain; diagnosed endoscopically.

Malignancies

  • Kaposi sarcoma (HHV-8): Violaceous cutaneous/visceral lesions.
  • Non-Hodgkin lymphoma (EBV-driven): Primary CNS lymphoma, Burkitt lymphoma.
  • Invasive cervical cancer (HPV): Screen per guidelines.

Other Complications

  • HIV-associated neurocognitive disorders (HAND): Memory, executive function, motor slowing.
  • Wasting syndrome: >10% weight loss + chronic diarrhea/fever/weakness.
  • Renal, hepatic, cardiovascular, metabolic complications from chronic inflammation and ART toxicity.

Modern Management

Antiretroviral Therapy (ART) suppresses viral replication, allows immune reconstitution, and prevents AIDS. Current guidelines recommend immediate ART initiation at diagnosis. With sustained viral suppression (<50 copies/mL), life expectancy approaches normal, and AIDS-defining illnesses become rare.

Prophylaxis (e.g., TMP-SMX for PCP) is indicated when CD4 <200 until immune recovery on ART.

HIV & AIDS - Related Articles